Apr 23, 2009
RESULTS OF A PROOF OF CONCEPT STUDY (C210) OF TELAPREVIR
MONOTHERAPY AND IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAÏVE GENOTYPE 4 HCV PATIENTS
Y. Benhamou1, J. Moussalli1, V. Ratziu2, P. Lebray1, V. Gysen3, K. de Backer3, A. Ghys3, R. van Heeswijk3, T. Vangeneugden3, G. Picchio4, M. Beumont-Mauviel3
1Hôpital Pitié-Salpêtrière, 2Université Pierre et Marie Curie, Paris VI, Paris, France, 3Tibotec BVBA, Mechelen, Belgium, 4Tibotec Inc.